Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1

Neuland Laboratories Limited (NSE: NEULANDLAB; BSE: 524558), a global contract development and manufacturing organisation (CDMO) specialising in complex APIs, has entered into a development partnership with LIR Life Sciences Corp, a Canada‑based biotechnology company focused on scalable and accessible obesity treatments, in advancing its cell‑penetrating peptide (CPP) platform.   As part of this engagement, Neuland […]

FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media

FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company specializing in cell therapy using umbilical cord mesenchymal stromal cells (MSC), today announced a global commercial launch resulting from their strategic collaboration. The offering consists of FUJIFILM Biosciences’ PRIME-XV MSC Expansion XSFM medium and NextCell’s first commercial product, […]

Symeres appoints Henning Steinhagen as CEO to drive next phase of strategic growth

Symeres, a leading transatlantic CRDMO for drug discovery and development, today announced the appointment of Henning Steinhagen as Chief Executive Officer, marking a key transition as the company scales its operations and broadens its market reach. Dr. Steinhagen succeeds Guillaume Jetten, who has served as CEO and played a key role in strengthening the company’s […]

Hongene Demonstrates Advanced Oligonucleotide CDMO Capabilities Through Support of SiranBio’s Dual-Target siRNA Program

Hongene Biotech Corporation today announced its support of SiranBio’s SA1211 program, a dual-target siRNA candidate for chronic hepatitis B, underscoring Hongene’s ability to deliver end-to-end development and manufacturing solutions for structurally complex oligonucleotide therapeutics. Hongene supported the SA1211 program with vertically integrated CDMO services spanning raw materials production, process development, analytical development, cGMP drug substance […]

Syngene strengthens leadership team with two key appointments to support next phase of growth

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced the Abhijit Zutshi as Chief Commercial Officer (CCO) and Maninder Kapoor Puri as Chief Human Resources Officer (CHRO), effective 1 May 2026. Abhijit (Abhi) Zutshi joins Syngene as Chief Commercial Officer and will be based in the United States. As a member of […]

AddParts bolsters pharmaceutical manufacturing resilience with funding to support virtual storeroom innovations

AddParts, a UK-based technology company enabling pharmaceutical manufacturers to improve production continuity and reduce operational risk, has secured a six-figure pre-seed investment from SFC Capital to support its growth. The move comes as pharmaceutical manufacturers face increasing pressure to mitigate operational risk, reduce dependency on fragile supply chains, and maintain continuous production in highly regulated […]

Alcami Completes Acquisition of Tjoapack

Alcami Corporation (“Alcami”), a leading U.S.-based contract development and manufacturing organization (CDMO), today announced the completion of the acquisition of Tjoapack, a leading global contract packaging organization with facilities in the United States and the Netherlands. The combined organization now employs over 1,400 skilled personnel across the U.S. and the Netherlands. This expands the operational […]

HAS Healthcare Advanced Synthesis Group Announces Strategic Investments in Biodelphis Therapeutics

HAS Healthcare Advanced Synthesis and Biodelphis Therapeutics announced the signing of a strategic agreement to support the development and GMP manufacturing of Antibody Protease Inhibitor Conjugates, an emerging class of targeted therapeutics designed to selectively inhibit disease‑driving proteases. This collaboration combines HAS Group long‑standing expertise in complex bioconjugation, process development, and clinical‑grade manufacturing with Biodelphis […]

Ardena Strengthens Executive Team to Drive its Next Phase of Growth

Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further strengthen Ardena’s executive leadership team as the company continues to scale its operations and commercial reach globally. Ben Ash joins […]

Ecolab Life Sciences Opens Bioprocessing Applications Lab in Korea to Support Downstream Process Development Across Asia

Ecolab Life Sciences is expanding the bioprocessing business with the launch of a new Bioprocessing Applications Lab (BPAL) in Dongtan, Korea, giving biopharmaceutical manufacturers across Asia better local access to downstream process development support. Strategically located to serve customers throughout the region, the site is Ecolab’s first bioprocessing facility in Asia and joins an established […]